Dhaliwal Harpreet S.: insider trades.
Dhaliwal Harpreet S. reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($935K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Dhaliwal Harpreet S.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Vaxcyte, Inc. (PCVX) | Officer · Chief Technical Ops Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Vaxcyte, Inc. | F | 7,651 | $60.36 | 68,085 | Form 4 |
| 2026-09-02 | Vaxcyte, Inc. | F | 659 | $61.58 | 75,736 | Form 4 |
| 2026-08-31 | Vaxcyte, Inc. | F | 361 | $60.74 | 76,395 | Form 4 |
| 2026-08-05 | Vaxcyte, Inc. | S | 17,000 | $55 | 76,756 | Form 4 |
| 2026-08-05 | Vaxcyte, Inc. | M | 17,000 | $24.79 | 93,756 | Form 4 |
Questions
What stock did Dhaliwal Harpreet S. buy or sell?
Dhaliwal Harpreet S. reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($935K), across 1 company.
Is Dhaliwal Harpreet S. the same person as other filers with this name?
This page covers SEC CIK 1886794 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/dhaliwal-harpreet-s-1886794.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.